18 May 2009

Update - LSUHSC to conduct study of hyperbaric treatment for TBI & PTSD

There are still eight slots available to Army patients for participation in this study. The other service branches have filled their quota.

If you or anyone you know was injured while serving in the Army and is experiencing either or PTSD and/or TBI, please pass this on!

Previously posted:

LSUHSC to conduct study of hyperbaric treatment for TBI & PTSD

Dr. Paul Harch, an LSU Health Sciences Center emergency medicine professor, has been treating TBI with hyperbaric oxygen for 19 years and is starting a pilot study for vets with chronic TBI and PTSD.

The study will examine 30 participants, half with TBI and half with TBI and PTSD.

Round trip airfare to New Orleans will be provided to all veterans approved for the study. Depending on branch of service, housing and meals are free or at highly discounted rates.

For more information or to find out if you qualify, call 504-309-1445 or 504-309-4948



New Orleans, LA – Dr. Paul Harch, LSUHSC Clinical Associate Professor of Emergency Medicine, is the principal investigator of a pilot study to determine the effectiveness of one or two courses of hyperbaric oxygen therapy in treating chronic traumatic brain injury (TBI) and TBI with post traumatic stress disorder (PTSD). The study grew out of previous experience in treating TBI with hyperbaric oxygen therapy with improvement in symptoms and function.

Thirty participants will be recruited – half will have traumatic brain injury and half will have both traumatic brain injury and post traumatic stress disorder. The participants will undergo oral, written, and computers tests, as well as an MRI (if the participant has not had one since injury) and SPECT brain imaging. Participants will have 40 hyperbaric oxygen therapy treatments and can request up to 40 more if not improved to his/her satisfaction. ...

We would also like to thank the heroes who have fought for this country in Iraq and Afghanistan, who are the participants in the study."

No comments: